Alumis Inc.

Biotechnology • Healthcare • South San Francisco, CA, United States • ALMS (NMS)

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company's clinical asset comprises ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. It also develops interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

$ALMS stock is down 11% today. Here's what we see in our data. - Quiver Quantitative

Quiver Quantitative • Jan 2

Alumis (NASDAQ:ALMS) Shares Down 3.7% - What's Next? - MarketBeat

MarketBeat • Dec 30

Will Upcoming ONWARD Data Drive Alumis' Stock Forward? - RTTNews

RTTNews • Nov 17

Alumis stock hits 52-week high at 11.3 USD - Investing.com

Investing.com • Dec 8

Alumis Faces Legal Dispute Over Unpaid Budoprutug Milestone - TipRanks

TipRanks • Jan 2

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ALUMIS INC. had layoffs?

No layoff events have been recorded for ALUMIS INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does ALUMIS INC. have?

ALUMIS INC. has approximately 221 employees.

What industry is ALUMIS INC. in?

ALUMIS INC. operates in the Biotechnology industry, within the Healthcare sector.

Is ALUMIS INC. a publicly traded company?

Yes, ALUMIS INC. is publicly traded under the ticker symbol ALMS on the NMS. The company has a market capitalization of approximately $1.19 billion.

Where is ALUMIS INC. headquartered?

ALUMIS INC. is headquartered in South San Francisco, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.